147 related articles for article (PubMed ID: 22512445)
21. [Perioperative heparin bridging is rarely indicated].
Nielsen JD; Münster AM; Husted SE
Ugeskr Laeger; 2016 Feb; 178(9):V12150952. PubMed ID: 26957485
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulation in children: Making the most of little patients and little evidence.
Young G; Male C; van Ommen CH
Blood Cells Mol Dis; 2017 Sep; 67():48-53. PubMed ID: 28552476
[TBL] [Abstract][Full Text] [Related]
23. Heparin-like macromolecules for the modification of anticoagulant biomaterials.
Ran F; Nie S; Li J; Su B; Sun S; Zhao C
Macromol Biosci; 2012 Jan; 12(1):116-25. PubMed ID: 21976247
[TBL] [Abstract][Full Text] [Related]
24. [Strategies for utilization of anticoagulants in pulmonary embolism].
Fartoukh M; Simonneau G
Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444
[TBL] [Abstract][Full Text] [Related]
25. Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-l-lysine: A comparative 'in vitro' study versus protamine sulfate.
Muralidharan-Chari V; Kim J; Mousa SA
Thromb Res; 2017 Jul; 155():128-130. PubMed ID: 28538195
[No Abstract] [Full Text] [Related]
26. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).
Koracevic G
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):198-9. PubMed ID: 20118712
[No Abstract] [Full Text] [Related]
27. Anticoagulant drugs.
Br Med J; 1969 Feb; 1(5640):365-7. PubMed ID: 5762842
[No Abstract] [Full Text] [Related]
28. Bleeding complications of unfractionated heparin.
Krishnaswamy A; Lincoff AM; Cannon CP
Expert Opin Drug Saf; 2011 Jan; 10(1):77-84. PubMed ID: 20868290
[TBL] [Abstract][Full Text] [Related]
29. [Low molecular weight heparin in venous thromboembolism. Mechanism of action, therapy and prophylaxis].
Stammler F; Diehm C
Dtsch Med Wochenschr; 1998 May; 123(19):604-11. PubMed ID: 9618643
[No Abstract] [Full Text] [Related]
30. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
[TBL] [Abstract][Full Text] [Related]
31. Tailored glycopolymers as anticoagulant heparin mimetics.
Oh YI; Sheng GJ; Chang SK; Hsieh-Wilson LC
Angew Chem Int Ed Engl; 2013 Nov; 52(45):11796-9. PubMed ID: 24123787
[TBL] [Abstract][Full Text] [Related]
32. Management of anticoagulation in the critically ill patient.
Toale KM
Crit Care Nurs Clin North Am; 2013 Dec; 25(4):471-80, vi. PubMed ID: 24267283
[TBL] [Abstract][Full Text] [Related]
33. Activated partial thromboplastin time monitoring in patients receiving unfractionated heparin for venous thromboembolism in relation to clinical outcomes.
Vardi M; Laor A; Bitterman H
Thromb Haemost; 2009 Nov; 102(5):879-86. PubMed ID: 19888523
[TBL] [Abstract][Full Text] [Related]
34. [Avoiding emergency situations under anticoagulant therapy with vitamin K antagonists].
Dempfle CE; Borggrefe M
Internist (Berl); 2005 Sep; 46(9):1006-10, 1012-3. PubMed ID: 16082525
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
36. Immobilization of heparin: approaches and applications.
Murugesan S; Xie J; Linhardt RJ
Curr Top Med Chem; 2008; 8(2):80-100. PubMed ID: 18289079
[TBL] [Abstract][Full Text] [Related]
37. Nanocarriers in Improved Heparin Delivery: Recent Updates.
Kurmi BD; Tekchandani P; Paliwal R; Paliwal SR
Curr Pharm Des; 2015; 21(30):4509-18. PubMed ID: 26295952
[TBL] [Abstract][Full Text] [Related]
38. Oral anticoagulation and implantation of cardiac rhythm management devices: is heparin a bridge too far?
Kakouros N
Hellenic J Cardiol; 2013; 54(2):150-1. PubMed ID: 23557618
[No Abstract] [Full Text] [Related]
39. Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA
Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
[TBL] [Abstract][Full Text] [Related]
40. Low molecular weight heparin.
Vanpee D; Gillet JB; Swine C
Ann Emerg Med; 2000 Sep; 36(3):277-8. PubMed ID: 10969239
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
